These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7602078)

  • 1. New nucleoside analogues for chronic hepatitis B.
    Schalm SW; de Man RA; Heijtink RA; Niesters HG
    J Hepatol; 1995; 22(1 Suppl):52-6. PubMed ID: 7602078
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New developments in antiviral therapy for chronic hepatitis B infection.
    De Man RA; Heijtink RA; Niesters HG; Schalm SW
    Scand J Gastroenterol Suppl; 1995; 212():100-4. PubMed ID: 8578221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [New approaches in the treatment of hepatitis B].
    Sagir A; Avci A; Erhardt A; Lörke J; Heintges T; Häussinger D
    Dtsch Med Wochenschr; 2004 May; 129(21):1203-8. PubMed ID: 15160325
    [No Abstract]   [Full Text] [Related]  

  • 4. Nucleoside analogues and other investigational modalities for the treatment of chronic hepatitis B.
    Fried MW; Sommadossi JP
    Antivir Ther; 1996 Apr; 1(2):71-6. PubMed ID: 11321182
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiviral therapy to prevent and treat hepatitis B virus infection in hepatic allografts.
    Perrillo RP
    Clin Transplant; 2000; 14 Suppl 2():25-8. PubMed ID: 10965961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resolution of recurrent hepatitis B in two liver transplant recipients treated with famciclovir.
    Han SH; Kinkhabwala M; Martin P; Holt C; Murray N; Seu P; Rudich S; Hiserodt D; Imagawa D; Busuttil RW
    Am J Gastroenterol; 1998 Nov; 93(11):2245-7. PubMed ID: 9820407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial injury. Lessons from the fialuridine trial.
    Honkoop P; Scholte HR; de Man RA; Schalm SW
    Drug Saf; 1997 Jul; 17(1):1-7. PubMed ID: 9258627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of antiviral monotherapy and combination therapy for patients with hepatitis B virus infection after liver transplantation.
    Fischer L; Sterneck M; Meier D; Zöllner B; Rogiers X
    Transplant Proc; 2002 Sep; 34(6):2283-4. PubMed ID: 12270400
    [No Abstract]   [Full Text] [Related]  

  • 9. Successful antiviral treatment for fulminant reactivated hepatitis B after autologous stem cell transplantation and prophylaxis during subsequent allogeneic stem cell transplantation.
    Henkes M; Martin S; Einsele H; Aulitzky WE
    Ann Hematol; 2002 Jun; 81(6):343-6. PubMed ID: 12107567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic failure and lactic acidosis due to fialuridine (FIAU), an investigational nucleoside analogue for chronic hepatitis B.
    McKenzie R; Fried MW; Sallie R; Conjeevaram H; Di Bisceglie AM; Park Y; Savarese B; Kleiner D; Tsokos M; Luciano C
    N Engl J Med; 1995 Oct; 333(17):1099-105. PubMed ID: 7565947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical aspects of lamivudine and famciclovir against hepatitis B virus.
    Shaw T; Locarnini SA
    J Viral Hepat; 1999 Mar; 6(2):89-106. PubMed ID: 10607220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamivudine: a magic bullet for chronic hepatitis B?
    Grimm I
    Gastroenterology; 1996 Jul; 111(1):262-4. PubMed ID: 8698214
    [No Abstract]   [Full Text] [Related]  

  • 13. Posttransplantation: emerging and future therapies.
    Perrillo RP; Kruger M; Sievers T; Lake JR
    Semin Liver Dis; 2000; 20 Suppl 1():13-7. PubMed ID: 10895439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe toxicity of fialuridine (FIAU).
    Bari A
    N Engl J Med; 1996 Apr; 334(17):1135; author reply 1137-8. PubMed ID: 8598879
    [No Abstract]   [Full Text] [Related]  

  • 15. Therapy for chronic hepatitis B: nucleoside analogues in adult and pediatric patients.
    Conjeevaram HS
    Acta Gastroenterol Belg; 1998; 61(2):224-7. PubMed ID: 9658615
    [No Abstract]   [Full Text] [Related]  

  • 16. Combination therapy for hepatitis B.
    Di Bisceglie AM
    Gut; 2002 Apr; 50(4):443-5. PubMed ID: 11889057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of recurrence of hepatitis B in transplant patients.
    Berenguer M; Wright TL
    J Hepatol; 2003; 39 Suppl 1():S190-3. PubMed ID: 14708702
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic advances in the management of hepatitis B and hepatitis C.
    Nguyen MH; Wright TL
    Curr Opin Infect Dis; 2001 Oct; 14(5):593-601. PubMed ID: 11964881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histopathologic changes associated with fialuridine hepatotoxicity.
    Kleiner DE; Gaffey MJ; Sallie R; Tsokos M; Nichols L; McKenzie R; Straus SE; Hoofnagle JH
    Mod Pathol; 1997 Mar; 10(3):192-9. PubMed ID: 9071726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical course of four patients receiving the experimental antiviral agent fialuridine for the treatment of chronic hepatitis B infection.
    Stevenson W; Gaffey M; Ishitani M; McCullough C; Dickson R; Caldwell S; Lobo P; Pruett T
    Transplant Proc; 1995 Feb; 27(1):1219-21. PubMed ID: 7878856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.